| Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in … DP Taufik Momin, Kevinkumar Kansagra, Hardik Patel, Sunil Sharma, Bhumika ... EClinicalMedicine 38 (https://doi.org/10.1016/j.eclinm.2021.10), 2021 | 173 | 2021 |
| Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India PK Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande ... The Lancet 399 (10332), 1313-1321, 2022 | 170 | 2022 |
| Transfusion transmitted leishmaniasis: a case report and review of literature A Dey, S Singh Indian Journal of Medical Microbiology 24 (3), 165, 2006 | 144 | 2006 |
| Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models A Dey, TMC Rajanathan, H Chandra, HPR Pericherla, S Kumar, ... Vaccine 39 (30), 4108-4116, 2021 | 116 | 2021 |
| Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood G Saletti, N Çuburu, JS Yang, A Dey, C Czerkinsky Nature protocols 8 (6), 1073, 2013 | 97 | 2013 |
| Applications of molecular methods for Leishmania control S Singh, A Dey, R Sivakumar Expert review of molecular diagnostics 5 (2), 251-265, 2005 | 75 | 2005 |
| Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model J Mishra, A Dey, N Singh, R Somvanshi, S Singh The Indian journal of medical research 137 (4), 767, 2013 | 49 | 2013 |
| Leishmania-HIV co-infection: an emerging problem in India NS Redhu, A Dey, V Balooni, S Singh Aids 20 (8), 1213-1215, 2006 | 43 | 2006 |
| Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India A Dey, S Singh Infection, Genetics and Evolution 7 (2), 219-222, 2007 | 39 | 2007 |
| Influence of maternal and socioeconomic factors on breast milk fatty acid composition in urban, low‐income families U Nayak, S Kanungo, D Zhang, E Ross Colgate, MP Carmolli, A Dey, ... Maternal & child nutrition 13 (4), 2017 | 33 | 2017 |
| Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen … R Sivakumar, A Dey, P Sharma, S Singh Infection, genetics and evolution 8 (3), 313-322, 2008 | 33 | 2008 |
| The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis SE Park, T Toy, LM Cruz Espinoza, U Panzner, OD Mogeni, J Im, ... Clinical Infectious Diseases 69 (Supplement_6), S422-S434, 2019 | 29 | 2019 |
| Human circulating antibody-producing B cell as a predictive measure of mucosal immunity to poliovirus A Dey, NA Molodecky, H Verma, P Sharma, JS Yang, G Saletti, M Ahmad, ... PloS one 11 (1), e0146010, 2016 | 29 | 2016 |
| Kinesin motor domain of Leishmania donovani as a future vaccine candidate A Dey, P Sharma, NS Redhu, S Singh Clinical and Vaccine Immunology 15 (5), 836-842, 2008 | 25 | 2008 |
| First case of indigenous visceral leishmaniasis from central India A Dey, U Sharma, S Singh The American journal of tropical medicine and hygiene 77 (1), 95-98, 2007 | 25 | 2007 |
| Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection JO Kim, S Rho, SH Kim, H Kim, HJ Song, EJ Kim, RY Kim, EH Kim, ... Clinical and Vaccine Immunology 22 (4), 381-388, 2015 | 24 | 2015 |
| A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi N Kothari, S Kothari, YJ Choi, A Dey, DE Briles, DK Rhee, R Carbis Vaccine 33 (6), 783-788, 2015 | 20 | 2015 |
| Use of immunoglobulin G avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients NS Redhu, A Dey, V Balooni, S Singh Clinical and vaccine immunology 13 (8), 969-971, 2006 | 19 | 2006 |
| Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection PD Yadav, S Kumar, K Agarwal, M Jain, DR Patil, K Maithal, B Mathapati, ... BioRxiv, 2021 | 18 | 2021 |
| Enumeration of gut-homing β7-positive, pathogen-specific antibody-secreting cells in whole blood from enterotoxigenic Escherichia coli-and Vibrio cholerae-infected patients … TR Bhuiyan, MR Hoq, NS Nishat, D Al Mahbuba, R Rashu, K Islam, ... Clinical and Vaccine Immunology 23 (1), 27-36, 2016 | 12 | 2016 |
Prof. Sarman Singh, MDAarupadai Veedu Medical College (AVMC)在 avmc.edu.in 的电子邮件经过验证
